| Identification | Back Directory | [Name]
Benzenamine, 3,6-dichloro-2-methyl- | [CAS]
62077-26-3 | [Synonyms]
Dasatinib Impurity 92
3,6-dichloro-2-methylaniline
3,6-Dichloro-2-methylbenzenamine | [Molecular Formula]
C7H7Cl2N | [MDL Number]
MFCD20699076 | [MOL File]
62077-26-3.mol | [Molecular Weight]
176.04 |
| Chemical Properties | Back Directory | [Boiling point ]
260.4±35.0 °C(Predicted) | [density ]
1.334±0.06 g/cm3(Predicted) | [solubility ]
DCM | [form ]
Solid | [pka]
1.45±0.10(Predicted) | [color ]
Yellow |
| Hazard Information | Back Directory | [Uses]
3,6-Dichloro-2-methylaniline is an intermediate in the synthesis of 5-Chloro-dasatinib (C364925), an impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product. |
|
|